PRF Technologies Ltd.

PRF Technologies Ltd. (PRFX) priced its initial public offering on Sep 2, 2020 at $7.99 per share, raising $20M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $71.2M. Maxim Group was lead-left underwriter, joined by Joseph Gunnar. Carter Ledyard & Milburn advised the company and Ellenoff Grossman & Schole and Meitar advised the underwriters.

PRF Technologies Ltd. is a clinical-stage specialty pharmaceutical company that reformulates established drugs using its extended release drug-delivery system. The aim is to give extended post-surgical pain relief without repeat dosing and reduce possible opiate use, using the FDA's 505(b)(2) approval pathway.

Status

IPO

Ticker

PRFX

Exchange

Nasdaq Capital Market

Priced

Sep 2, 2020

IPO price

$7.99

Raised

$20M

Market cap at IPO price

$71.2M

First filed

Jun 30, 2020

Underwriters

Maxim Group and Joseph Gunnar

Company counsel

Carter Ledyard & Milburn

Underwriters' counsel

Ellenoff Grossman & Schole and Meitar

Sector

Biotech & pharma

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.